Enovis (ENOV)

• Market cap: $2.41B
• 1 day: 1.48%
• 5 days: -6.30%
• 1 month: -3.71%
• 3 months: -1.26%
• 6 months: -3.23%
• Year to date: -22.22%
• 1 year: -21.54%
• 5 years: 21.23%
• 10 years: -17.63%
• Sector: Healthcare
• Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies

About: Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.

Employees: 6,550

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

142% more call options, than puts

Call options by funds: $72.4M | Put options by funds: $29.8M

40% more repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 85

3% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 37

0% more funds holding

Funds holding: 282 [Q2] → 283 (+1) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

3.8% less ownership

Funds ownership: 112.39% [Q2] → 108.59% (-3.8%) [Q3]

6% less capital invested

Capital invested by funds: $2.78B [Q2] → $2.61B (-$168M) [Q3]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $58 35% upside
• Avg. target: $62 43% upside
• High target: $65 51% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Needham Mike Matson 50% 1-year accuracy 58 / 117 met price target	51% upside $65	Buy Reiterated	7 Nov 2024
JMP Securities David Turkaly 29% 1-year accuracy 7 / 24 met price target	44% upside $62	Market Outperform Initiated	3 Oct 2024
Evercore ISI Group Vijay Kumar 60% 1-year accuracy 28 / 47 met price target	35% upside $58	Outperform Maintained	1 Oct 2024